Nothing Special   »   [go: up one dir, main page]

Wang et al., 2023 - Google Patents

Targeting intracellular and extracellular receptors with nano-to-macroscale biomaterials to activate immune cells

Wang et al., 2023

Document ID
9367403525706196472
Author
Wang B
Cui H
Kiessling F
Lammers T
Baumjohann D
Shi Y
Publication year
Publication venue
Journal of Controlled Release

External Links

Snippet

Activation of immune cells is an essential process in innate and adaptive immunity. A high number of immune cell activation pathways have been discovered, which are stimulated via various intra-and extracellular receptors. Small-molecule and macromolecular agonists …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid

Similar Documents

Publication Publication Date Title
Wang et al. Targeting intracellular and extracellular receptors with nano-to-macroscale biomaterials to activate immune cells
Lei et al. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy
Lee et al. Vaccine adjuvants to engage the cross-presentation pathway
Kowalczyk et al. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
Sun et al. Injectable hydrogels coencapsulating granulocyte-macrophage colony-stimulating factor and ovalbumin nanoparticles to enhance antigen uptake efficiency
Baker et al. The role of FcRn in antigen presentation
JP2023160828A (en) Particles encapsulating fusion proteins containing linked epitopes
Kohno et al. Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal
Tullett et al. Harnessing human cross-presenting CLEC9A+ XCR1+ dendritic cells for immunotherapy
EA202091816A1 (en) METHOD OF DRUG DELIVERY TO MUSCLE
JP2019515044A (en) DNA monoclonal antibodies that target checkpoint molecules
MX2019007714A (en) Article for treating diabetic peripheral neuropathy.
Dumont et al. Controlled release strategies for modulating immune responses to promote tissue regeneration
Kim et al. Combination of sunitinib and PD-L1 blockade enhances anticancer efficacy of TLR7/8 agonist-based nanovaccine
MX2013014461A (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same.
WO2017161360A4 (en) Multimodal vector for dendritic cell infection
WO2017044803A8 (en) Expression vector delivery system and use thereof for inducing an immune response
US20220347308A1 (en) Methods and means for inducing an immune response
Liu et al. Hyaluronidase-functionalized silica nanocarrier for enhanced chemo-immunotherapy through inducing immunogenic cell death
Prakash mRNA-based nanomedicine: A new strategy for treating infectious diseases and beyond
MX2017003377A (en) Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans.
WO2020176900A1 (en) Galectin-1/ galectin-3 chimeras and multivalent proteins
CA3212593A1 (en) Dna-encoded bispecific antibodies targeting il13r?2 and methods of use in cancer therapeutics
Zafar et al. Innovative approaches in immunomodulation for cell-based therapies. Agrobiological Records 19: 59-70
Dalal et al. Functionalized Poly (ethylene Glycol) Diacrylate Scaffolds for In Situ Immunomodulation of Dendritic Cells Targeting Melanoma Tumor